Lantern Pharma: Using AI to Transform Drug Development
Lantern Pharma (Nasdaq: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. The Company’s proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, Lantern Pharma has accelerated the development of its growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, Lantern Pharma’s newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program. Learn more at LTRNinfo.com.
-
0:16
RedChip
1 year agoLantern Pharma: Redefining Oncology Drug Development with A.I. and Machine Learning
11 -
0:17
RedChip
1 year agoLantern Pharma: Redefining Oncology Drug Development with A.I. and Machine Learning
11 -
4:13
The Igonrant Entrepreneur
11 months agoThe First AI-Generated Drug Enters Human Trials, Pioneering a New Era in Medicine!
22 -
1:39
thestonebuildersrejected
11 months agoAI Applications In Drug Development And Discovery
4 -
8:04
TheExPharmacist's Rumble Channel - a guide to free yourself from the Industrial Medical Complex
3 months agoExposing Big Pharma: The Power, Profits, and Pitfalls
155 -
21:30
jess93
1 month agoBig Pharma CEO PFIZER New Blockbuster Drugs Saving The World and His Prediction About Cancer Drug
611 -
27:24
TheRealTruthAboutHealth
6 months agoPioneering Personalized Treatments for Advanced Cancers: A Conversation with Dr. Dawn Lemanne
215 -
1:48:18
Power of the Pulse
1 year agoSYNTHETIC BIOLOGY (the TAKEOVER)
3414 -
59:14
Life Lessons with Dr. Bob
4 months agoEp44 The BIG Money of BIG Pharma with Dr. Aaron Goodman
45 -
4:15
FineTimer
1 year agoAI and Healthcare: Revolutionizing Medicine
61